Influence of long-chain polyunsaturated fatty acids on oxidation of low density lipoprotein.
Enrichment of low density lipoprotein (LDL) with long-chain fatty acids, such as eicosapentaenoic acid (EPA; 20:5 n-3) and docosahexaenoic acid (DHA; 22:6 n-3) found in fish oil, is thought to increase its oxidative susceptibility although such an increase has not been clearly demonstrated. The purpose of this study was to determine the composition and fatty acid concentration of LDL obtained from postmenopausal women given a supplement of fish oil and relate these values to its oxidative susceptibility. Fish oil supplementation significantly increased LDL concentration of EPA (P = 0.0001) and DHA (P = 0.0001) and decreased that of linoleic acid P = 0.006). The concentration of free cholesterol, cholesterol ester, phospholipids and protein was unchanged while triglyceride concentration increased 8% (P = 0.02). Cu2+-mediated oxidation resulted in a shorter lag time, slower oxidation rate and similar concentrations of conjugated dienes of EPA/DHA-enriched LDL than EPA/DHA-unenriched LDL. Stepwise multiple regression indicated that the primary predictor of oxidative susceptibility of LDL was linoleic acid, even after enrichment with EPA and DHA. The oxidation rate of EPA/DHA-unenriched LDL correlated with the cholesteryl ester concentration (P = 0.003) while that of EPA/DHA-enriched correlated with the concentration of phospholipids (P = 0.03). These data suggest that EPA/DHA-enriched LDL have decreased oxidative susceptibility and that surface lipids may mediate its rate of oxidation.
Wander
R C
RC
Department of Nutrition and Food Management, Oregon State University, Corvallis 97331, USA. wanderr@ccmail.orst.edu
Du
S H
SH
Thomas
D R
DR
D002784:Cholesterol / Q000032:analysis / Q000097:blood; D002788:Cholesterol Esters / Q000032:analysis / Q000097:blood; D003300:Copper / Q000378:metabolism; D019587:Dietary Supplements; D004281:Docosahexaenoic Acids / Q000032:analysis / Q000097:blood; D015118:Eicosapentaenoic Acid / Q000032:analysis / Q000097:blood; D005231:Fatty Acids, Unsaturated / Q000008:administration & dosage / Q000032:analysis*; D005260:Female; D005395:Fish Oils / Q000008:administration & dosage*; D006801:Humans; D007700:Kinetics; D019787:Linoleic Acid / Q000032:analysis / Q000097:blood; D008077:Lipoproteins, LDL / Q000737:chemistry / Q000378:metabolism*; D008875:Middle Aged; D010084:Oxidation-Reduction; D010743:Phospholipids / Q000032:analysis / Q000097:blood; D017698:Postmenopause; D012044:Regression Analysis; D014280:Triglycerides / Q000032:analysis / Q000097:blood; D014810:Vitamin E / Q000032:analysis
D002788:Cholesterol Esters; D005231:Fatty Acids, Unsaturated; D005395:Fish Oils; D008077:Lipoproteins, LDL; D010743:Phospholipids; D014280:Triglycerides; D014810:Vitamin E; D004281:Docosahexaenoic Acids; D003300:Copper; D002784:Cholesterol; D019787:Linoleic Acid; D015118:Eicosapentaenoic Acid